untargeted metabolomics provides a comprehensive platform for identifying metabolites whose levels are altered between two or more populations. By using liquid chromatography quadrupole time-of-flight mass spectrometry (lc-Q-toF-Ms), hundreds to thousands of peaks with a unique m/z ratio and retention time are routinely detected from most biological samples in an untargeted profiling experiment. each peak, termed a metabolomic feature, can be characterized on the basis of its accurate mass, retention time and tandem mass spectral fragmentation pattern. Here a seven-step protocol is suggested for such a characterization by using the MetlIn metabolite database. the protocol starts from untargeted metabolomic lc-Q-toF-Ms data that have been analyzed with the bioinformatics program XcMs, and it describes a strategy for selecting interesting features as well as performing subsequent targeted tandem Ms. the seven steps described will require 2-4 h to complete per feature, depending on the compound.
IntroDuctIon
Metabolomics has emerged as a powerful technique for understanding the small-molecule basis of biological processes such as those associated with disease pathogenesis 1,2 , interactions of microbial communities 3 , microbial biochemistry 4, 5 , plant physiology 6 , drug mode of action 7 and metabolism 8 . In general, there are two technological platforms used to perform metabolomics, which involve either nuclear magnetic resonance (NMR) spectroscopy 9, 10 or MS 11, 12 . Although NMR provides unique structural information about metabolites, it suffers from limitations in sensitivity and chemical resolution. In contrast, MS provides less-conclusive structural information, but given its sensitivity and large dynamic range, it allows for the detection of many more chemical species in a single experiment. Each of these technologies has been successfully applied to systematically studying metabolites; however, MS methods are more commonly used for comprehensive investigations that are global in scope. The strength of MS-based metabolomics is best realized when coupled to a chromatographic technique, such as capillary electrophoresis, gas chromatography (GC) or LC, the latter two being the most popular. GC/MS-based metabolomics is a robust, well-established technique [13] [14] [15] . Because of the reproducibility of the chromatography, retention time can be paired with the electron impact-derived fragmentation spectra 16 and compared against the National Institute of Standards and Technology (NIST) 17 or Fiehn metabolomic 18 databases to make identifications. However, the majority of metabolites must be derivatized to make them more volatile and more thermally stable, which introduces a source of error and complicates identification 19 .
In the past decade, LC/MS-based analysis has moved to the forefront because of its ability to analyze and identify underivatized and thermally labile metabolites. In contrast with electron impact (EI), electrospray ionization (ESI) 20 (and, to a lesser extent, atmospheric pressure chemical ionization 20 ) is a soft mechanism for ionizing molecules, leaving the molecular ion intact. There are two major approaches to LC/MS-based metabolomic experiments: the targeted [21] [22] [23] and untargeted [24] [25] [26] [27] [28] analysis. In untargeted metabolomics, one tries to observe as many unknown and known metabolic peaks as possible, comparing the ion intensity between the same peaks present in two or more groups of samples. The disadvantage of this technique is that it is not optimized for a specific metabolite and is less quantitative. The advantage is that it provides an opportunity to observe a large number of known and unknown metabolites, which may provide novel insights into a biological system 3, 5, 29 . Coupled to a high-resolution mass spectrometer 30 , such as a TOF 22, 31 , Orbitrap 32, 33 or a Fourier transform-ion cyclotron resonance (FT-ICR) 34 instrument, high mass accuracy can be obtained. This can greatly reduce the number of potential molecular formulas corresponding to one metabolic peak, but there may still be several possible molecular formulas that are appropriate for the accurate mass data (depending on the resolution of the instrument), and numerous potential isomers for each molecular formula. More structural information can be obtained by examining the fragmentation pattern. Combining the high-resolution precursor ion with data from a fragmentation mechanism (obtained by MS/MS) reduces the number of possible metabolites to a single structure or a narrow set of structures (see limitations below). When searching against a metabolite database-in the case of this protocol, the METLIN database 35 (http://metlin.scripps.edu)-it is therefore best to match both the accurate mass and the fragmentation data (MS/MS spectra) for each metabolite peak. Retention times, relative to other metabolites of known identity and similar structural class, also support the structural determination. This protocol describes an approach to provide rigorous characterization of metabolites from LC/MS-based metabolomic data.
Q-TOF-based characterization of metabolites
In this protocol, metabolites are characterized using an LC-Q-TOF instrument in combination with the METLIN database 35 (http:// metlin.scripps.edu). The Q-TOF provides the ability to collect both high-resolution precursor and fragmentation data, facilitating the characterization of metabolites. When used in conjunction with the METLIN database, which provides the user with the ability to search for the precursor ion, its fragments and neutral losses, the characterization of metabolites is highly augmented. METLIN is the largest curated database of high-resolution tandem mass spectra, covering over 10,000 metabolites. The fragmentation spectra are essential for the elucidation and confirmation of metabolites. Matching the retention time and fragmentation of a metabolite with those of an authentic standard can confirm its identity. One of the advantages of tandem MS in the Q-TOF is that collision energies can be adjusted to enhance or decrease the degree of fragmentation, thereby revealing more information about the metabolite. Some metabolites, however, do not fragment well or fragment poorly when an adduct (e.g., Na + ) is present. The adduct stabilizes the ion and can give limited fragmentation, but trying different ionization strategies or solvent mixtures can ameliorate this.
Untargeted metabolomics begins with an initial profiling experiment, often in which two or more sample groups are profiled via LC-MS and statistically compared, with only the dysregulated metabolites being characterized [2] [3] [4] 6, 29, 36 . There are a few exceptions in which only one sample group is analyzed in studies characterizing as many metabolites as possible in one biofluid 37, 38 . Two excellent protocols are available for LC-MS profiling experiments in urine 39 and in plasma and serum 14 . These protocols can be easily adjusted to other sample types. The key to obtaining good results is to carefully design the experiments so that there are enough biological replicates to make the results statistically significant (i.e., they must not be underpowered). Appropriate power calculations must be carried out first to determine the sample size that will have a statistically significant effect 40 . There are a number of factors that need to be considered, such as biological variation, sample preparation and others; these are discussed in more detail by Brown et al. 41 . Depending on the biological variability of the system, we recommend that the minimal numbers of each sample group be four to six for cell culture, six to eight for animals and ten or more for humans. After analysis of the initial profiling data by using a peak alignment and statistical analysis package, such as XCMS 42 or XCMSOnline 43 , a list of dysregulated metabolic peaks with a retention time and m/z will be generated. The protocol reported here is for the systematic analysis of the dysregulated features on this list. The stages of the procedure are as follows: (i) determine the adduct and charge of a metabolite feature of interest; (ii) inspect MS data to determine whether a peak is real and of sufficient intensity for MS/MS; (iii) perform targeted MS/MS; (iv) search precursor in METLIN; (v) search MS/MS in METLIN; (vi) compare experimental MS/MS with METLIN; and (vii) verify that the characterization is correct using a standard.
Limitations of this approach
Many of the limitations listed below can be mitigated using specialized MS techniques, and thus may not impose real challenges. It is, however, very important to consider these points when carrying out general metabolomic approaches and before optimizing methods for specific chemical species or in response to specific problems.
First, low-abundance ions can be hard to identify if the precursor ion intensity is low (generally below 5,000 counts for an Agilent Q-TOF), making it difficult to obtain the high-quality fragment spectra needed to support a structural assignment. This is not, however, a problem for many peaks, and examples of high-sensitivity MS-based metabolite identifications include 3.5 fmol of dimethylsphingosine (DMS) per mg of dorsal horn 36 , or an upperattomolar range in the analysis of Methylobacterium extroquens AM1 (ref. 44) .
Second, MS-based analysis provides little, if any, information about the stereochemistry of the metabolites identified and is often insufficient to determine the positions of double bonds in acyl tails. Some specialized techniques have been developed to overcome this problem and have involved the use of ion mobility 45 , the addition of Li + with multiple rounds of fragmentation 46 and ozone-induced dissociation 47 . The location of these bonds may be important; for example, isobaric ω-3 or ω-6 isomers of a lipid can have markedly different biological roles 48 .
Third, isobaric species that co-elute will provide a convoluted mass spectrum, making it difficult to characterize either species. MS is prone to ion suppression 49 ; therefore, co-eluted species also affect the quantification of molecules and reduce the ability to observe ions that are less capable of ionization in the presence of an interfering metabolite. Furthermore, isobaric and other species with very similar masses could be fragmented together if not well isolated, thus introducing contamination into the MS/MS spectra and hindering characterization, possibly leading to false negatives. Appropriate chromatographic methods can be developed, which can help resolve different species and reduce some issues with ion suppression. Ion mobility can also aid in the separation of isobaric species in gas phase, which reduces contamination of MS/MS spectra.
Fourth, in-source fragmentation is sometimes observed for species containing a labile group. It can generate one or more abundant fragments that show a similar level of dysregulation compared with other peaks at the same retention time 44 . If two or more dysregulated peaks co-elute, one must ensure that the peaks are not fragments from the same molecule. In Supplementary  Figure 1 , an example of this is shown in which two species (m/z of 339.2892 and m/z 480.3084) with the same retention time are observed to be dysregulated. The peak 480.3085 corresponds to a lysoPE(18:1/0:0), whereas 339.2892 is a major fragment of this lysoPE, a dehydrated oleoyl (18:1) glycerol. Without recognizing that the lysoPE is the dysregulated metabolite, one may falsely identify the in-source fragment, oleoyl glycerol, as a dysregulated metabolite.
In addition, new tandem MS techniques, such as MS E (from Waters) and SWATH (from AB Sciex), have recently emerged. MS/MS data acquired from MS E and SWATH techniques have not yet been tested with METLIN MS/MS spectral comparison.
Finally, this approach does not provide an unequivocal identification of a metabolite. It does, however, provide a higher level of confidence than high-resolution mass alone. To quantitatively evaluate the confidence of metabolite identification, a scoring system is under development. For better confidence, standards should be acquired and run on the same instrument with the same instrument parameters. The retention time and fragmentation patterns must then match between the sample and the standard to extend the Q-TOF-based characterization to identification, and if the retention time does not match it implies that the characterization is incorrect. For metabolites in which a higher level of confidence is needed, an orthogonal method should also be used to validate the metabolite structure.
NMR, for example, has the benefit of structural identification and accurate characterization; furthermore, when coupled to LC, it can be highly effective for metabolite elucidation 50 . Metabolites lacking commercial standards should be chemically synthesized and compared as above 5, 51 . For some experiments, this level of rigor may be unnecessary, depending on the scope of the biological question 2 . 4| Select Chromatograms → Extract Chromatograms. In Type, select EIC.
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5|
On the MS Chromatogram tab, set the MS level to MS; for m/z value(s), type in your value.
6|
On the Advanced tab, define the single m/z expansion to a symmetric parts per million (p.p.m.) value. For this example, 496.3409, ±20 ppm was used. Click OK. The EIC should appear as in Figure 1b , and a peak with an appropriate retention time (RT) for your peak of interest should be visible. The EIC will also display other species with very similar m/z, indicating isobaric species that may be present.
7|
With the Walk Chromatogram cursor selected, click on the EIC at the retention time of your peak of interest. The MS spectrum will appear.
8| By using the Range Select cursor, zoom in on the MS spectra as in Figure 1c . 9| Zoom in further on the MS spectrum ( Fig. 1d) and determine the charge for the peak. As there is a series of isotope peaks ~1 Da larger after the most intense peak, it is singly charged. Subtracting the proton provides the neutral mass for this species of 495.3336. ? trouBlesHootInG stage 2: Inspect the Ms data to determine whether the peak is real and of sufficient intensity 10| Look for co-eluting ions within 1-2 m/z of the peak of interest in the MS spectra, as these may have convoluted the fragment spectra. In Figure 2 , a group of peaks is observed in which the separation is insufficient. Several species, such as m/z 480.2805, m/z 480.3082 and m/z 482.2569, are not resolved and will fragment together, creating convoluted MS/MS spectra (Fig. 2b) . Once the species m/z 480.3082 is fully resolved by chromatography (Fig. 2c) , the generated MS/MS spectrum shows good spectral purity. In addition to achieving high-quality MS/MS spectra, the feature of interest should have an intensity greater than 5,000 (for an Agilent Q-TOF). The intensity requirement is empirical. Other Q-TOF instruments from different vendors may have different intensity requirements. The parent ion intensity is required to ensure that the MS/ MS spectra have sufficient signal-to-noise ratios (S/N). If the peak is not pure (i.e., with co-eluting species within 1-2 m/z) or intense enough, it will be difficult to obtain good MS/MS spectra and thus a meaningful characterization. 
13|
Input the m/z value of the feature, set an RT window of at least 1 min and set isolation to medium, unless co-eluting species dictate a narrower window. More than one feature may be programmed as needed. 
14|
16|
In the mass widow, input the accurate mass value of the parent ion (Fig. 3) .
17|
Select the charge and adducts determined in Stage 1 (Steps 8 and 9).
18|
The default and maximum tolerance of 30 ppm is generally acceptable for Q-TOF experiments; adjust the parameters as appropriate for your specific mass spectrometer. Generally, it is best to use a slightly wider window than the theoretical tolerance for an instrument. 
21|
Use the Walk Chromatogram cursor to click on individual scans at and near your peak of interest.
22|
Inspect the individual MS/MS scans at and around this RT to assess spectral purity. Often a portion of the precursor ion will remain intact, making it easier to identify the spectrum of interest and assess spectral purity. Generally, if a similar fragmentation pattern is consistently seen across a few scans, and the MS spectrum lacks co-eluting species within a few m/z, then the spectra can be considered pure and sufficiently intense to identify the peak of interest.
? trouBlesHootInG 23| Scroll through the metabolites returned by the METLIN search in Stage 4 to find ones with MS/MS data (indicated by a 'View' button) (Fig. 4) .
24|
Click on 'View' . The spectrum will appear (Fig. 5) .
25| Click on individual lines in the spectral table to select a specific precursor and voltage; the appropriate spectrum will appear. You can right-click and drag a box to zoom in. Roll your cursor over a spectral peak and the exact mass for the fragment will be displayed along with a predicted structure for that fragment if available. Click 'Reset zoom' in the upper left to zoom back out. Right-click and hold 'move' to move the spectral window around the page. To close, click on 'close' in the upper right corner.
stage 6: compare experimental Ms/Ms with MetlIn 26| Compare your experimental spectra with the spectra in METLIN by visual inspection. If the same fragment ions are present in the experimental spectra and the METLIN spectra with very similar intensity ratios, you have a match, as seen for phenylalanine (Fig. 6a) , arachidonic acid (Fig. 6b) and hypoxanthine in positive and negative modes (Fig. 6c,d) . Hypoxanthine in positive mode (Fig. 6c) is a good match, as the major experimental fragments are of similar intensity as the standard, although there is some low-intensity contamination. If you find an acceptable match, you can go to Stage 7.
If several high-intensity ions are missing or the ratios are markedly different (as seen in Fig. 7 , in which the intensity ratios between the experimental spectra in black are different from the standard spectra in red), you have not found a match. ? trouBlesHootInG stage 7: Verify that the characterization is correct using a standard 27| If you found an exact match between your experimental spectra at both the precursor and fragment levels, then you have characterized the metabolite. Depending on the level of confidence needed in your analysis, you should follow up with additional techniques to support your identification. Techniques such as FTICR-MS or NMR can give you an additional level of confidence, although metabolite concentrations often prevent the use of NMR to characterize metabolites. The highest level of confidence is obtained when standards are synthesized or purchased, and compared by LC-MS/MS to confirm retention time and MS/MS with the same parameters.
? trouBlesHootInG Stage 1: If it is determined that your metabolic peak of interest is an isotope peak, one must be cautious that this may be a false positive. If your peak is an adduct other than M + H or M − H, one should look back at the original profiling experiment to see whether the monoisotopic peak or M + H or M − H is also dysregulated. If this is the case, complete this protocol with the M + H or M − H ion. If it is not dysregulated, do another simple search in METLIN with the correct adduct selected. As we discussed above (supplementary Fig. 1) , in-source fragments should also be checked. These in-source fragments always co-elute with their parent ions. If the in-source fragment ion is identified, one should look for the parent ion at the same retention time. If the parent ion is also dysregulated, complete this protocol with the parent ion. Stage 2: If a co-eluting metabolic peak is within 1-2 m/z of your ion of interest, it may provide a convoluted spectrum. If you suspect that this is the case, you should refragment this species with a narrower isolation window. If it is within 1 Da, this may not be sufficient to isolate the species, and you may need to use another approach to identify this peak. If two ions are co-eluting, different chromatographic conditions may allow these two species to be separated as in Figure 2 .
Stage 4: If no metabolites are returned from the search, you can increase the tolerance value, or add additional adducts if appropriate. For the ionic metabolites, when searching the METLIN database, the 'neutral' should be chosen for the 'charge' setting. In addition, the isotopic pattern distribution also helps predict the empirical formula of unknown compounds. 53 , the relative intensities of fragment ions in MS/MS spectra may be slightly different, depending on the instrument settings. In addition, MS/MS spectra in METLIN database are acquired with an isolation window of 1.3 Da, and thus there is no isotopic peak for fragment ions. When MS/MS spectra in Stage 3 are acquired with a wider isolation window (e.g., 4 Da), one should expect that isotopic peaks will be shown in the MS/MS spectra. • tIMInG This protocol should take 2-4 h, depending on the metabolite.
antIcIpateD results
This protocol allows one to characterize a peak of interest in an untargeted metabolomic experiment if it is a metabolite found in METLIN, or is an analog of a metabolite in METLIN. Metabolites that are not in METLIN or not analogs of known metabolites are difficult to identify with this technique, although this protocol will provide information that would be valuable when used in combination with other analytical techniques. Some cases that have proved challenging when attempting to identify unknown metabolites are discussed below; they include examples of metabolites that have no exact match in METLIN and metabolites that co-elute with other metabolic peaks of similar m/z.
For our first example, the metabolic peak of interest has an m/z of 496.3409 and an RT of 24.5. The ion spectrum is extracted (Fig. 1c) from the TIC, and upon inspection of the spectrum at m/z 496.3409 another peak is observed at m/z 518.3219, which is 21.981 amu larger. This is characteristic of the [M + Na] + peak and supports the fact that m/z 496.3409 is the [M + H] + peak (Na + − H + = 21.9820). As also noted (Fig. 1d) , two isotope peaks for the m/z 496.3409 peak can be seen, m/z 497.3440 and m/z 498.3455. As these peaks are approximately + 1 and + 2 from the [M + H] + peak, it adds validation that this is a singly charged ion and that m/z 496.3409 is indeed the protonated monoisotopic mass of the molecule.
To determine the structure of the species at 480.3082 in (Fig. 2d) , which is characterized as lysoPE(18:1/0:0). The use of a narrow isolation window may also be useful to prevent contamination by other species if the mass difference of two species is sufficient.
The characterization of three metabolites, phenylalanine, arachidonic acid and hypoxanthine, is depicted in Figure 6 . The simple fragmentation of the experimental phenylalanine (Fig. 6a) and the more complex arachidonic acid (Fig. 6b) match the standard METLIN spectra in both intensity ratio and accurate mass of the fragments, supporting their identification. The experimental spectrum for hypoxanthine in negative mode (Fig. 6d) matches well with the METLIN spectrum, although there is substantially more contamination in the experimental sample than observed in positive mode (Fig. 6c) . The observation that hypoxanthine is dysregulated in both positive and negative modes also supports the characterization of this peak.
In addition to the MS/MS pattern, the retention time is another key parameter to consider. As seen in Figure 4 , a search for m/z 137.0450 returns seven hits. The first five hits (such as threonate) are organic acids, and the remaining two hits (allopurinol and hypoxanthine) are more basic metabolites. The two types of metabolites could be differentiated by their retention time and ionization efficiency using positive-mode ESI. This helps narrow down the candidates before comparing MS/MS spectra. However, to further differentiate allopurinol and hypoxanthine, MS/MS matching is necessary. . In a separate analysis, DMS (peak 5) was observed, which is isobaric with sphingosine C-20 (peak 2) and stearoyl ethanolamide (not observed in this analysis). Top, the MS/MS spectra of DMS (black) acquired at the collision energy of 20 V and 40 V, respectively. Bottom, the MS/MS spectra of sphingosine C-20 (red) in METLIN database with the collision energy of 20 V and 40 V, respectively. Comparison of the experimental spectra of DMS against sphingosine C-20 reveals a poor match because of different ratios between the higher intensity species at 20 V and a poor correlation in the lower mass species at 40 V.
